Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic ACTH in membranous nephropathy: pilot study
2008-001647-19Phase 2Active
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tetracosactide hexaacetate in membranous glomerulonephritis (MGN) and nephrosis, sponsored by Radboud University Medical Center. Primary endpoint: Attainability of ACTH therapy. Started Jun 2008; status: active.
02
Drugs
tetracosactide hexaacetate
03
Conditions
membranous glomerulonephritis (MGN)nephrosis
Beyond the preview
Go deeper on 2008-001647-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001647-19.